Review
Published on 10 Aug 2022
The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.982231
- 4,680 views
- 17 citations
Type at least 3 characters
1,766 articles
Articles
Editorial
Published on 10 Aug 2022
Editorial: Liquid biopsy: A tool for better understanding of the metastatic process ecosystem
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.951158
- 1,400 views
Case Report
Published on 08 Aug 2022
Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.934887
- 2,014 views
- 5 citations
Case Report
Published on 05 Aug 2022
Case report and literature review: thyroid carcinoma showing intrathyroid thymic carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.923683
- 2,604 views
- 1 citation
Original Research
Published on 05 Aug 2022
Design and Fabrication of a Liver-on-a-chip Reconstructing Tissue-tissue Interfaces
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.959299
- 5,407 views
- 21 citations
Original Research
Published on 05 Aug 2022
Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.971594
- 2,644 views
- 3 citations
Original Research
Published on 05 Aug 2022
Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.971475
- 2,056 views
- 6 citations
Original Research
Published on 05 Aug 2022
Upregulation of XIAP promotes lung adenocarcinoma brain metastasis by modulating ceRNA network
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.946253
- 1,871 views
- 4 citations
Original Research
Published on 05 Aug 2022
Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.933446
- 3,063 views
- 4 citations
Original Research
Published on 02 Aug 2022
A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.952849
- 4,211 views
- 11 citations
Original Research
Published on 02 Aug 2022
Synthesis and anti-melanoma effect of 3-O-prenyl glycyrrhetinic acid against B16F10 cells via induction of endoplasmic reticulum stress-mediated autophagy through ERK/AKT signaling pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.890299
- 2,736 views
- 5 citations
Case Report
Published on 02 Aug 2022
Patient-Derived Organoid Facilitating Personalized Medicine in Gastrointestinal Stromal Tumor With Liver Metastasis: A Case Report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.920762
- 3,822 views
- 4 citations
Original Research
Published on 01 Aug 2022
Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.912881
- 1,923 views
- 1 citation
Case Report
Published on 01 Aug 2022
Identification of a novel FGFR2-KIAA1217 fusion in esophageal gastrointestinal stromal tumours: A case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.884814
- 2,149 views
- 3 citations
Review
Published on 01 Aug 2022
Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.923260
- 6,622 views
- 10 citations
Systematic Review
Published on 01 Aug 2022
Efficacy and safety of apatinib monotherapy for patients with advanced breast cancer: a systematic review and meta-analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.940171
- 2,076 views
- 2 citations